Medibank Private Limited Financials

Market Capitalization A$10.19 Billion as of July 1, 2024

Valuations Metrics as of May. 5, 2024

Trailing PE	15.48
Forward PE	16.95
Price to Sales TTM	A$1.23
Price to Book MRQ	A$4.15
Enterprise to Revenue	0.83
Enterprise to EBITDA	6.86

Financial Reports as of Jun. 30, 2023

Financials

Fiscal Year Ends	2023-06-30
Most Recent Quarter	2023-06-30
Profit Margin	8.63%
Operating Margin	12.18%
Return on Assets TTM	15.24%
Return on Equity TTM	31.67%

Income Statement

Revenue TTM	A$7,944,399,872
Revenue per Share TTM	A$2.90
Quarterly Revenue Growth	12.40%
Gross Profit TTM	A$0
EBITDA	A$966,049,984
Net Income to Common TTM	A$685,400,000
Diluted EPS TTM	A$0.23
Quarterly Earnings Growth YoY	103.20%

Balance Sheet

Total Cash MRQ	A$3,145,999,872
Total Cash per Share MRQ	A$1.15
Total Debt MRQ	A$
Total Debt to Equity MRQ	0.00
Current Ratio MRQ	2.52
Book Value per Share MRQ	A$0.86

Cash Flow

Operating Cash Flow TTM	A$373,400,000
Levered Free Cash Flow TTM	A$80,487,504

MPL Stock Info as of May. 5, 2024

Stock Statistics

Shares Outstanding	2,753,999,872
Float Shares	2,741,975,808
Avg 10 Volume	5,278,613
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	0.52%
% Held by Institutions	38.02%

Stock Price Summary

Beta	0.11
Fifty Two Week Low	A$3.33
Fifty Two Week High	A$3.94
Fifty Two Week Change	-3.78%
Day 50 MA	A$3.73
Day 200 MA	A$3.60

Dividends and Splits

Forward Annual Dividend Rate	A$0.29
Forward Annual Dividend Yield	8.37%
Trailing Annual Dividend Rate	A$0.16
Trailing Annual Dividend Yield	4.51%
Payout Ratio	64.60%
Dividend Date
Ex Dividend Date	2024-02-29
Last Split Factor
Last Split Date